Immune surveillance: Paraneoplastic or environmental triggers of autoimmunity

Critical Reviews in Immunology

Volumn 17, Issue 5-6, 1997, Pages 437-447

  Lernmark, Åke ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoantibodies; Autoantigens; Autoimmune polyendocrine syndrome; Breast cancer; Glutamic acid decarboxylase; Insulin dependent diabetes; Thymoma

Indexed keywords

ANTIDIABETIC AGENT; AUTOANTIBODY; AUTOANTIGEN; BCG VACCINE; CYCLOSPORIN; DIAZOXIDE; FISH OIL; GLUTAMATE DECARBOXYLASE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INSULIN; NICOTINAMIDE; RICIN A; RICIN ANTIBODY; ROQUINIMEX; TUMOR ANTIGEN;

AUTOIMMUNITY; CANCER PREVENTION; CLINICAL TRIAL; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; ENVIRONMENTAL FACTOR; HUMAN; IMMUNOSURVEILLANCE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PUVA;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; AUTOANTIGENS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; ENVIRONMENTAL EXPOSURE; HUMANS; MOLECULAR SEQUENCE DATA; PARANEOPLASTIC SYNDROMES; POLYENDOCRINOPATHIES, AUTOIMMUNE;

EID: 0013674115     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (61)

1. Adams, T. E., Alpert, S., and Hanahan, D., Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic B cells, Nature, 325, 223-228, 1987.
2. Adamus, G., Aptsiauri, N., Guy, J., Heckenlively, J., Flannery, J., and Hargrave, P. A., The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy, Clin. Immunol. Immunopathol., 78, 120-129, 1996.
3. Atkinson, M. A., Bowman, M. A., Campbell, L., Darrow, B. L., Kaufman, D. L., and Maclaren, N. K., Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes [see comments], J. Clin. Invest., 94, 2125-2129, 1994.
4. Bach, J.-F., Insulin-dependent diabetes mellitus as an autoimmune disease, Endocrine Rev., 15, 516-542, 1994.
5. Bingley, P. J., Christie, M. R., Bonifacio, E., Bonifanti, R., Shattock, M., Fonte, M. T., Bottazzo, G. F., and Gale, E. A., Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives, Diabetes, 43, 1304-1310, 1994.
6. Bonifacio, E., Genovese, S., Braghi, S., Bazzigaluppi, E., Lampasona, V., Bingley, P. J., Rogge, L., Pastore, M. R., Bognetti, E., Bottazzo, G. F., Gale, E. A. M., and Bosi, E., Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity, Diabetologia, 38, 816-822, 1995.
7. Bottazzo, G. F., Dean, B. M., McNally, J. M., MacKay, E. H., Swift, P. G. F., and Gamble, D. R., In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med., 313, 353-360, 1985.
8. Brashear, H. R., Caccamo, D. V., Heck, A., and Keeney, P. M., Localization of antibody in the central nervous system of a patient with paraneoplastic encephalomyeloneuritis, Neurology, 41, 1583-1587, 1991.
9. Brashear, H. R. and Phillips, L. H., Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome, Neurology, 41, 158?-1592, 1991.
10. Dahlquist, G., Ivarsson, S., Lindberg, B., and Forsgren, M., Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM, Diabetes, 44, 408-413, 1995.
11. David, C., Solimena, M., and De Camilli, P., Autoimmunity in stiff-man syndrome with breast cancer is targeted to the C-terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161, FEBS Lett., 351, 73-79, 1994.
12. Efrat, S., Baekkeskov, S., Lane, D., and Hanahan, D., Coordinate expression of the endogenous p53 gene in beta cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes, EMBO J., 6, 2699-2704, 1987.
13. Endl, J., Otto, H., Jung, G., Dreisbusch, B., Donie, F., Stahl, P., Elbracht, R., Schmitz, G., Meinl, E., Hummel, M., Ziegler, A. G., Wank, R., and Schendel, D. J., Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients, J. Clin. Invest., 99, 2405-2415, 1997.
14. Fishman, P., Merimski, O., Baharav, E., and Shoenfeld, Y., Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo, Cancer, 79, 1461-1464, 1997.
15. Folli, F., Solimena, M., Cofieli, R., Austoni, M., Tallini, G., Fassetta, G., Bates, D., Cartlidge, N., Bottazzo, G. F., Piccolo, G., and De Camilli, P., Autoantibodies to a 128-kd synaptic protein in three women with the Stiff-Man syndrome and breast cancer, N. Engl. J. Med., 328, 546-551, 1993.
16. Foulis, A. K. and Stewart, J. A., The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue, Diabetologia, 26, 456-461, 1984.
17. Gepts, W., Pathologic anatomy of the pancreas in juvenile diabetes mellitus, Diabetes, 14, 619-633, 1965.
18. Greenbaum, C. J., Palmer, J. P., Kuglin, B., and Kolb, H., Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the fourth international workshop on the standardization of insulin autoantibody measurement, J. Clin. Endocrinol. Metab., 74, 1040-1044, 1992.
19. Greenbaum, C. J., Palmer, J. P., Nagataki, S., Yamaguchi, Y., Molenaar, J. L., van Beers, W. A. M., Maclaren, N. K., and Lernmark, Å., Improved specificity of ICA assays in fourth international immunology of diabetes serum exchange workshop, Diabetes, 41, 1570-1574, 1992.
20. Hagopian, W. A., Karlsen, A. E., Gottsater, A., Landin-Olsson, M., Grubin, C. E., Sundkvist, G., Petersen, J. S., Boel, E., Dyrberg, T., and Lernmark, Å., Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) showed 64K autoantibody positivity at onset predicts diabetes type, J. Clin. Invest., 91, 368-374, 1993.
21. Hagopian, W. A., Sanjeevi, C. B., Kockum, I., Landin-Olsson, M., Karlsen, A. E., Sundkvist, G., Dahlquist, G., Palmer, J., and Lernmark, Å., Glutamate decarboxylase-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children, J. Clin. Invest., 95, 1505-1511, 1995.
22. Hanahan, D., Transgenic mouse models of self-tolerance and autoreactivity by the immune system, Annu. Rev. Cell Biol., 6, 493-537, 1990.
23. Hänninen, A., Jalkanen, S., Salmi, M., Toikkanen, S., Nikolakaros, G., and Simell, O., Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus, J. Clin. Invest., 90, 1901-1910, 1992.
24. Hjelmstrom, P., Giscombe, R., Lefvert, A. K., Pirskanen, R., Kockum, I., Landin, O. M., and Sanjeevi, C. B., Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis, J. Neuroimmunol., 65, 125-131, 1996.
25. Hyöty, H., Hiltunen, M., Knip, M., Laakkonen, M., Vahaslo, P., Karjalaninen, J., Koskela, P., Roivainen, M., Leinikki, P., and Hovi, T., A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood diabetes in Finland (DiMe) study, Diabetes, 44, 652-657, 1995.
26. Ivarsson, S. A., Ackefors, M., Carlsson, A., Ekberg, G., Falorni, A., Kockum, I., Landin-Olsson, M., Lernmark, Å., Lindberg, B., Sundkvist, G., and Svanberg, L., Glutamate decarboxylase antibodies in non-diabetic pregnancies precedes insulin-dependent diabetes in the mother but not necessarily in the offspring, Autoimmunity, in press, 1996.
27. Jager, E., Ringhoffer, M., Altmannsberger, M., Arand, M., Karbach, J., Jager, D., Oesch, F., and Knuth, A., Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma, Int. J. Cancer, 71, 142-147, 1997.
28. Kaufman, D. J., Erlander, M. G., Clare-Salzler, M., Atkinson, M. A., Maclaren, N. K., and Tobin, A. J., Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus, J. Clin. Invest., 89, 283-292, 1992.
29. Kaufman, D. L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G. S. P., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J., and Lehman, P. V., Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes, Nature, 366, 69-72, 1993.
30. Kawakami, Y., Robbins, P. F., and Rosenberg, S. A., Human melanoma antigens recognized by T lymphocytes, Keio. J. Med., 45, 100-108, 1996.
31. Kockum, I., Sanjeevi, C. B., Eastman, S., Landin-Olsson, M., Dahlquist, G., and Lernmark, Å., Population analysis of protection by HLA-DR and DQ genes protection from insulin-dependent diabetes mellitus in Swedish insulin-dependent diabetes children and controls, Eur. J. Immunogenet., 22, 443-465, 1995.
32. Kuglin, B., Kolb, H., Greenbaum, C., Maclaren, N. K., Lernmark, Å., and Palmer, J. P., The fourth international workshop on the standardization of insulin autoantibody measurement, Diabetologia, 33, 638-639, 1990.
33. Kwok, W. W., Domeier, M. E., Johnson, M. L., Nepom, G. T., and Koelle, D. M., HLA-DQB1 codon 57 is critical for peptide binding and recognition, J. Exp. Med., 183, 1253-1258, 1996.
34. Kwok, W. W., Domeier, M. L., Raymond, F. C., Byers, P., and Nepom, G. T., Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase, J. Immunol., 156, 2171-2177, 1996.
35. Lambert, C. M. and Nuki, G., Multicentric reticulohistiocytosis with arthritis and cardiac infiltration: regression following treatment for underlying malignancy, Ann. Rheumatol. Dis., 51, 815-817, 1992.
36. Landin-Olsson, M., Karlsson, F. A., Lernmark, Å., and Sundkvist, G., Islet cell and thyrogastric anti-bodies in 633 consecutive 15-34 years old patients in the diabetes incidence study in Sweden (DISS), Diabetes, 41, 1022-1027, 1992.
37. Lang, B. and Vincent, A., Autoimmunity to ion-channels and other proteins in paraneoplastic disorders, Curr. Opin. Immunol., 8, 865-871, 1996.
38. Lernmark, Å., Glutamic acid decarboxylase. Gene to antigen to disease, J. Intern. Med., 240, 259-277, 1996.
39. Lernmark, Å., Klöppel, G., Stenger, D., Vathanaprida, C., Fait, K., Landin-Olsson, M., Baskin, D. G., Palmer, J. P., Gown, A. M., Petersen, J. S., Linsong, L., Edenvall, H., and Mauseth, R. S., Heterogeneity of human islet pathology in newly diagnosed childhood insulin-dependent diabetes mellitus. Macrophage infiltrations and expression of HLA-DQ and glutamic acid decarboxylase, Virchows Arch., 425, 631-640, 1995.
40. Lernmark, Å., Molenaar, J. L., vanBeers, W. A. M., Yamaguchi, Y., Nagataki, S., Ludvigsson, J., and Maclaren, N. K., The 4th int. serum exchange workshop to standardize cytoplasmic islet cell antibodies, in IDW Workshop in Nagasaki, Japan, Diabetologia, Springer-Verlag,
41. Moll, J. W., Hooijkaas, H., van Goorbergh, B. C., Roos, L. G., Hensen-Logmans, S. C., and Vecht, C. J., Systemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological diseases, J. Neurol., 243, 51-56, 1996.
42. Nepom, B. S., The role of the major histocompatibility complex in autoimmunity, Clin. Immunol. Immunopathol., 67, S50-55, 1993.
43. Nepom, B. S., Nepom, G. T., Coleman, M., and Kwok, W. W., Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules, Proc. Natl. Acad. Sci. U.S.A., 93, 7202-7206, 1996.
44. Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., and Paguette, T. L., Insulin antibodies in insulin-dependent diabetics before insulin treatment, Science, 222, 1337-1339, 1983.
45. Payton, M. A., Hawkes, C. J., and Christie, M. R., Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512), J. Clin. Invest., 96, 1506-1511, 1995.
46. Peterson, P., Perheentupa, J., and Krohn, K. J. E., Detection of candidal antigens in autoimmune polyglandular syndrome type 1, Clin. Diagn. Lab. Immunol., 3, 290-294, 1996.
47. Rabin, D. U., Pleasic, S. M., Shapiro, J. A., Yoo-Warren, H., Oles, J., Hicks, J. M., Goldstein, D. E., and Rae, P. M., Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases, J. Immunol., 152, 3183-3187, 1994.
48. Rubinfeld, B., Robbins, P., El, G. M., Albert, I., Porfiri, E., and Polakis, P., Stabilization of beta-catenin by genetic defects in melanoma cell lines [see comments], Science, 275, 1790-1792, 1997.
49. Sanjeevi, C. B., Falorni, A., Kockum, I., Hagopian, W. A., and Lernmark, Å., HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus, Diabetic Med., 13, 209-217, 1996.
50. Sanjeevi, C. B., Lybrand, T. P., DeWeese, C., Landin-Olsson, M., Kockum, I., Dahlquist, G., Sundkvist, G., Stenger, D., and Lernmark, Å., Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of insulin-dependent diabetes mellitus, Diabetes, 44, 125-131, 1995.
51. Schmidli, R. S., Colman, P. G., and Bonifacio, E., Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international glutamic acid decarboxylase workshop, Diabetes, 44, 636-640, 1995.
52. Schmidli, R. S., Colman, P. G., Bonifacio, E., Bottazzo, G. F., and Harrison, L. C., High level of concordance between assays for glutamic acid decarboxylase antibodies. The first international glutamic acid decarboxylase antibody workshop, Diabetes, 43, 1005-1009, 1994.
53. Skyler, J. S. and Marks, J. B., Immune intervention in type 1 diabetes mellitus, Diabetes, Rev., 1, 15-42, 1993.
54. Sterling, R. K., Ectopic ACTH syndrome associated with anorectal carcinoma. Report of a case and review of the literature, Digest Dis. Sci., 38, 955-959, 1993.
55. Sundkvist, G., Hagopian, W. A., Landin-Olsson, M., Lernmark, Å., Ohlsson, L., Ericsson, C., and Ahlmén, J., Islet cell antibodies (ICA) but not glutamic acid decarboxylase antibodies (GAD65-Ab) are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM), J. Clin. Endocrinol. Metab., 78, 1159-1165, 1994.
56. Tisch, R., Yang, X.-D., Singer, S. M., Liblau, R. S., Fugger, L., and McDevitt, H. O., Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice, Nature, 366, 72-75, 1993.
57. Tuomi, T., Björses, P., Falorni, A., Partanen, J., Perheentupa, J., Lernmark, Å., and Miettinen, A., Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I, J. Clin. Endocrinol. Metab., 81, 1488-1494, 1996.
58. Tuomi, T., Groop, L. C., Zimmet, P. Z., Rowley, M. J., Knowles, W., and Mackay, I. R., Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease, Diabetes, 42, 359-362, 1993.
59. Van, D. E. B., Peeters, O., De, B. O., Gaugler, B., Lucas, S., and Boon, T., A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma, J. Exp. Med., 182, 689-698, 1995.
60. Verge, C. F., Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M., Jackson, R. A., Chase, H. P., and Eisenbarth, G. S., Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and IC A512bdc/IA-2 autoantibodies, Diabetes, 45, 926-933, 1996.
61. Wicker, L. S., Chen, S. L., Nepom, G. T., Elliott, J. F., Freed, D. C., Bansal, A., Zheng, S., Herman, A., Lernmark, Å., Zaller, D. M., Peterson, L. B., Rothbard, J. B., Cummings, R., and Whiteley, P. J., Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401, J. Clin. Invest., 98, 2597-2603, 1996.